Breast cancer is a heterogeneous disease and is currently divided into subtypes in accordance with the status of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [1-3]. This evidence concerns the gene ESR1 and breast carcinoma.